Hadi J Minhas
Biographic Data
| ID | 8937807 |
|---|---|
| NAME | Hadi J Minhas |
| GIVEN NAMES | Hadi J |
| FAMILY NAME | Minhas |
| SIGNATURE | MINHAS H J |
| AFFILIATIONS | Department of Medicine, Albany Medical Center/Albany Medical College, Albany, NY, USA |
| ORCID | 0000-0002-0985-266X |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy
Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…
No prominent works on this page.
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy
Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…
Coinfection (1 work) · Drug (1 work) · Hepatitis C (1 work) · Hepatitis C virus research (1 work) · Heroin (1 work) · HIV/AIDS drug development and treatment (1 work) · HIV/AIDS Research and Interventions (1 work) · Immunology (1 work) · Internal Medicine (1 work) · Logistic regression (1 work)